Hepatic Oxidative Alterations in Patients with Extra-hepatic Cholestasis. Effect of Surgical Drainage
Overview
Affiliations
Background/aims: The mechanisms of liver injury in conditions of biliary obstruction are poorly understood. Hepatic oxidative injury has been observed in experimental models of cholestasis. Little is known in humans. This study aimed to gain more insights into the hepatic redox status in human cholestasis.
Methods: Liver concentrations of total glutathione, protein sulfhydryls and malondialdehyde (end-product of lipid peroxidation) were measured in hepatic specimens of 12 patients with obstructive jaundice before and after the application of an external biliary drainage and in six control subjects.
Results: Compared to control subjects, biliary obstructed patients showed significantly (P < 0.001) lower concentrations of hepatic glutathione and protein sulfhydryls, and higher (P < 0.001) levels of malondialdehyde, in the presence of comparable protein concentrations. Two-weeks after the application of external biliary drainage, cholestatic indices were significantly improved and the observed changes in glutathione, protein sulfhydryls and malondialdehyde levels, significantly decreased.
Conclusions: This study shows that cholestasis is associated with a decreased protein and non-protein sulfhydryl content in the liver and with an increased lipid peroxidation. These alterations reversed almost completely after biliary drainage, indicating the cholestasis itself as the determining factor for the redox status impairment observed in the liver of patients with extra-hepatic biliary obstruction.
Tang X, Ning J, Zhao Y, Feng S, Shao L, Liu T J Intensive Med. 2025; 5(1):79-88.
PMID: 39872844 PMC: 11763227. DOI: 10.1016/j.jointm.2024.06.003.
Wang D, Lin H, Guan C, Zhang X, Li P, Xin C Front Oncol. 2022; 12:1037671.
PMID: 36439415 PMC: 9686320. DOI: 10.3389/fonc.2022.1037671.
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
Iruzubieta P, Goikoetxea-Usandizaga N, Barbier-Torres L, Serrano-Macia M, Fernandez-Ramos D, Fernandez-Tussy P JHEP Rep. 2021; 3(3):100276.
PMID: 33997750 PMC: 8099785. DOI: 10.1016/j.jhepr.2021.100276.
Fetal androgen exposure is a determinant of adult male metabolic health.
Siemienowicz K, Filis P, Shaw S, Douglas A, Thomas J, Mulroy S Sci Rep. 2019; 9(1):20195.
PMID: 31882954 PMC: 6934666. DOI: 10.1038/s41598-019-56790-4.
Shearn C, Fennimore B, Orlicky D, Gao Y, Saba L, Battista K Free Radic Biol Med. 2019; 143:101-114.
PMID: 31377417 PMC: 6848778. DOI: 10.1016/j.freeradbiomed.2019.07.036.